Insider trades
Nant Capital, 10% Owner of ImmunityBio IBRX, has filed 24 purchases and 0 sales on the open market. The latest trade was on 03/31.
Nant Capital
10% Owner
- Company
- ImmunityBio IBRX
- First filing
- 23/03/27
- Trades
- 53 trades
- Buys / sales
- 24 / 0
- 12-month net buying
- No record
- Last trade
- 03/31
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 24/02/15 | 24/02/20 | 442,298 sh | $1.52 | $672,292.96 | No record | |
| Open-market buy | 23/09/01 | 23/09/06 | 7,360 sh | $6.49 | $47,766.4 | +0.8% | |
| Open-market buy | 23/08/28 | 23/08/30 | 15,921,888 sh2 trades | $1.00avg. | $15,998,632.16 | No record | |
| Open-market buy | 23/06/22 | 23/06/26 | 634,251 sh | $0.23 | $145,877.73 | +2.0% | |
| Open-market buy | 23/06/16–23/06/21 | 23/06/21 | 366,659 sh3 trades | $0.23avg. | $83,931.09 | +1.2% | |
| Open-market buy | 23/06/13–23/06/15 | 23/06/15 | 1,725,906 sh3 trades | $0.20avg. | $351,854.84 | +5.7% | |
| Open-market buy | 23/06/07–23/06/09 | 23/06/09 | 3,735,098 sh3 trades | $0.23avg. | $859,409.91 | +14.1% | |
| Open-market buy | 23/06/01–23/06/02 | 23/06/05 | 180,012 sh2 trades | $0.24avg. | $43,419.45 | +0.7% | |
| Open-market buy | 23/04/13 | 23/04/17 | 7,077 sh | $0.25 | $1,769.25 | +0.0% | |
| Open-market buy | 23/04/10–23/04/12 | 23/04/12 | 540,650 sh3 trades | $0.25avg. | $135,162.5 | +2.1% | |
| Open-market buy | 23/04/05–23/04/06 | 23/04/10 | 1,026,051 sh2 trades | $0.25avg. | $252,662.51 | +4.2% | |
| Open-market buy | 23/03/23–23/03/24 | 23/03/27 | 1,334,051 sh2 trades | $0.23avg. | $307,381.02 | +131.9% |